Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical leader founded in 1887, specializing in the discovery, development, and manufacturing of prescription medications. The organization maintains a robust portfolio focused on high-impact therapeutic areas, including oncology, cardiovascular disease, immunoscience, and virology. By leveraging advanced scientific research, the company addresses complex patient needs, particularly in treating chronic viral infections and various forms of cancer. Its commitment to innovation is supported by a collaborative research model that integrates internal capabilities with strategic external partnerships to accelerate the development of next-generation therapeutic solutions.

Operating with a significant global footprint, Bristol-Myers Squibb manages 53 locations worldwide to ensure efficient distribution and patient access to its specialized medication portfolio. The company supports a workforce of over 10,000 employees dedicated to advancing medical science and improving patient outcomes. Learn about Bristol-Myers Squibb's global headquarters for detailed information regarding their operational presence in Princeton, New Jersey, and their broader international infrastructure. This extensive network facilitates the seamless integration of research, manufacturing, and commercial operations across diverse geographic markets.

As a major player in the pharmaceutical sector, Bristol-Myers Squibb competes with industry giants like Pfizer, Merck, and Roche. The company reported annual revenue of $48.5B, reflecting its strong market position and sustained investment in R&D. Meet Bristol-Myers Squibb's team to explore the leadership driving these strategic initiatives, or Explore financial highlights for a comprehensive overview of their fiscal performance and funding history. Through its focus on unmet medical needs and high-value therapeutic innovation, the organization continues to maintain a competitive edge in theView more...